BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17659562)

  • 21. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
    Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias.
    Guerrini L; Belli G; Mazzoni L; Foresti S; Ginestroni A; Della Nave R; Diciotti S; Mascalchi M
    J Magn Reson Imaging; 2009 Jul; 30(1):11-7. PubMed ID: 19557841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
    Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
    J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective longitudinal proton magnetic resonance spectroscopic imaging in adult traumatic brain injury.
    Holshouser BA; Tong KA; Ashwal S; Oyoyo U; Ghamsary M; Saunders D; Shutter L
    J Magn Reson Imaging; 2006 Jul; 24(1):33-40. PubMed ID: 16755529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
    Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
    Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT; Law M; Naidich TP; Leeds NE
    J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
    NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
    Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
    Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
    Schocke MF; Berger T; Felber SR; Wolf C; Deisenhammer F; Kremser C; Seppi K; Aichner FT
    Neuroimage; 2003 Oct; 20(2):1253-63. PubMed ID: 14568494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.
    Tartaglia MC; Narayanan S; De Stefano N; Arnaoutelis R; Antel SB; Francis SJ; Santos AC; Lapierre Y; Arnold DL
    J Neurol; 2002 Oct; 249(10):1382-90. PubMed ID: 12382153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomical and metabolic assessment of prostate using a 3-Tesla MR scanner with a custom-made external transceive coil: healthy volunteer study.
    Kaji Y; Kuroda K; Maeda T; Kitamura Y; Fujiwara T; Matsuoka Y; Tamura M; Takei N; Matsuda T; Sugimura K
    J Magn Reson Imaging; 2007 Mar; 25(3):517-26. PubMed ID: 17279524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
    Tong Z; Yamaki T; Harada K; Houkin K
    Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of quantitative cerebral T2 relaxometry, diffusion tensor imaging, and 1H magnetic resonance spectroscopy at 3.0 Tesla.
    Jansen JF; Kooi ME; Kessels AG; Nicolay K; Backes WH
    Invest Radiol; 2007 Jun; 42(6):327-37. PubMed ID: 17507802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative multivoxel proton spectroscopy of the brain in developmental delay.
    Verbruggen KT; Maurits NM; Meiners LC; Brouwer OF; van Spronsen FJ; Sijens PE
    J Magn Reson Imaging; 2009 Oct; 30(4):716-21. PubMed ID: 19787717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI, volumetry, 1H spectroscopy, and cerebropetal blood flowmetry in childhood idiopathic anatomic megalencephaly.
    Koudijs SM; van der Grond J; Hoogendoorn ML; Hulshoff Pol HE; Schnack HG; Witkamp TD; Gooskens RH; van Nieuwenhuizen O; Braun KP
    J Magn Reson Imaging; 2006 Aug; 24(2):282-7. PubMed ID: 16786580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil.
    Kaji Y; Wada A; Imaoka I; Matsuo M; Terachi T; Kobashi Y; Sugimura K; Fujii M; Maruyama K; Takizawa O
    J Magn Reson Imaging; 2002 Dec; 16(6):697-706. PubMed ID: 12451583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.